Synonym
Lilly 51641; Lilly-51641; Lilly51641; LY 51641; LY-51641; LY51641;
IUPAC/Chemical Name
N-(2-(2-chlorophenoxy)ethyl)cyclopropanamine
InChi Key
MUWKAPGYHBLRER-UHFFFAOYSA-N
InChi Code
InChI=1S/C11H14ClNO/c12-10-3-1-2-4-11(10)14-8-7-13-9-5-6-9/h1-4,9,13H,5-8H2
SMILES Code
ClC1=CC=CC=C1OCCNC2CC2
Purity
>98% (or refer to the Certificate of Analysis)
Shipping Condition
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition
Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility
Soluble in DMSO
Shelf Life
>3 years if stored properly
Drug Formulation
This drug may be formulated in DMSO
Stock Solution Storage
0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code
2934.99.03.00
Preparing Stock Solutions
The following data is based on the
product
molecular weight
211.68
Batch specific molecular weights may vary
from batch to batch
due to the degree of hydration, which will
affect the solvent
volumes required to prepare stock solutions.
Concentration / Solvent Volume / Mass |
1 mg |
5 mg |
10 mg |
1 mM |
1.15 mL |
5.76 mL |
11.51 mL |
5 mM |
0.23 mL |
1.15 mL |
2.3 mL |
10 mM |
0.12 mL |
0.58 mL |
1.15 mL |
50 mM |
0.02 mL |
0.12 mL |
0.23 mL |
1: Wong KL, Tyce GM. Pyridoxal 5'-phosphate levels in brain after treatments which impair cerebral glucose metabolism. Neurochem Res. 1979 Dec;4(6):821-6. PubMed PMID: 44547.
2: Porsolt RD, Pawelec C, Roux S, Jalfre M. Discrimination of the amphetamine cue. Effects of A, B and mixed type inhibitors of monoamine oxidase. Neuropharmacology. 1984 May;23(5):569-73. PubMed PMID: 6429563.
3: Mefford IN, Roth KA, Jurik SM, Collman V, McIntire S, Tolbert L, Barchas JD. Epinephrine accumulation in rat brain after chronic administration of pargyline and LY 51641--comparison with other brain amines. Brain Res. 1985 Jul 29;339(2):342-5. PubMed PMID: 2411347.
4: Fuller RW, Hemrick-Luecke SK, Perry KW. Deprenyl antagonizes acute lethality of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in mice. J Pharmacol Exp Ther. 1988 Nov;247(2):531-5. PubMed PMID: 3141609.
5: Fuller RW, Snoddy HD, Perry KW. Tissue distribution, metabolism and effects of bufotenine administered to rats. Neuropharmacology. 1995 Jul;34(7):799-804. PubMed PMID: 8532147.
6: Fuller RW, Hemrick-Luecke SK. Elevation of epinephrine concentration in rat brain by LY51641, a selective inhibitor of type A monoamine oxidase. Res Commun Chem Pathol Pharmacol. 1981 May;32(2):207-21. PubMed PMID: 7244360.
7: Fuller RW, Hemrick-Luecke SK, Kindt MV, Heikkila RE. Different effects of monoamine oxidase inhibition on MPTP depletion of heart and brain catecholamines in mice. Life Sci. 1988;42(3):263-71. PubMed PMID: 3121972.
8: Barwell CJ, Canham CA. A method for stabilization of monoamine oxidases in homogenates of rat intestine epithelium. J Pharm Pharmacol. 1988 Mar;40(3):217-8. PubMed PMID: 2899157.
9: May T, Strauss S, Rommelspacher H. [3H]Harman labels selectively and with high affinity the active site of monoamine oxidase (EC 1.4.3.4) subtype A (MAO-A) in rat, marmoset, and pig. J Neural Transm Suppl. 1990;32:93-102. PubMed PMID: 2128516.
10: Fuller RW, Hemrick-Luecke SK, Molloy BB. N-[2-(o-iodophenoxy)ethyl]cyclopropylamine hydrochloride (LY121768), a potent and selective irreversible inhibitor of type A monoamine oxidase. Biochem Pharmacol. 1983 Apr 1;32(7):1243-9. PubMed PMID: 6847714.